< Back to search
Filter
1
Active & Responsive

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

for
Somatostatin Receptor Positive, NETs, Lymphoma, Solid Tumor,
Location: Philadelphia PA, Houston TX, San Francisco CA
Sponsor: ITM Solucin GmbH

Sex: All

Age: 2 - 18

Code: NCT06441331

Phase1, Recruiting
Active & Responsive

Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT07673367

Phase2, Recruiting
Active & Responsive

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07101328

Phase1, Recruiting
Active & Responsive

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

for
Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL),
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT07478848

Phase1, Recruiting
Active & Responsive

A Study of ARC-02 in B-cell NHL

for
B-cell Non Hodgkin Lymphoma
Location: Spokane WA, Los Angeles CA
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07691606

Phase1, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma,
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 4+

Code: NCT07652580

Recruiting
Active & Responsive

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,
Location: Boston MA, Atlanta GA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07020533

Phase1, Recruiting
Active & Responsive

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

for
Lymphoma, Myeloma, Cytokine Release Syndrome,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 21+

Code: NCT07390071

Recruiting
Active & Responsive

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

for
Mantle Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06357676

Phase1, Phase2, Recruiting
Active & Responsive

Amping up With PemJAK

for
Non-Hodgkin Lymphoma, Hodgkin Disease Lymphoma,
Location: New York NY
Sponsor: Seda S. Tolu

Sex: All

Age: 18 - 70+

Code: NCT07283822

Phase2, Recruiting
Active & Responsive

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

for
CD30-Positive Diffuse Large B-Cell Lymphoma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 12 - 70+

Code: NCT06176690

Phase1, Recruiting
Active & Responsive

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

for
Hodgkin Lymphoma, Adult, Refractory Hodgkin Lymphoma,
Location: San Francisco CA
Sponsor: Michael Spinner, MD

Sex: All

Age: 18+

Code: NCT07021989

Phase2, Recruiting
Active & Responsive

CD45BE-HSPC + CART-45 Cells

for
B-Cell Non-Hodgkin Lymphoma (NHL), Richter's Transformation,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07451054

Phase1, Recruiting
Active & Responsive

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

for
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV,
Location: Toronto, Calgary
Sponsor: AstraZeneca

Sex: All

Age: 18

Code: NCT07509151

Phase3, Recruiting
Active & Responsive

Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07283679

Phase1, Phase2, Recruiting
Active & Responsive

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

for
CLL / SLL, CLL (Chronic Lymphocytic Leukemia),
Location: Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06708897

Phase1, Recruiting
Active & Responsive

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

for
Chronic Lymphocytic Leukemia (CLL),
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07428707

Early_phase1, Recruiting
Active & Responsive

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

for
Recurrent Acute Lymphoblastic Leukemia,
Location: Columbus OH
Sponsor: Sumithira Vasu

Sex: All

Age: 2+

Code: NCT05418088

Phase1, Recruiting
Active & Responsive

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

for
Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory,
Location: New York NY, Madison WI, Kansas City KS, Austin TX,
Sponsor: Marker Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05798897

Phase1, Recruiting
Active & Responsive

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health

Sex: All

Age: 0+

Code: NCT01793168

Recruiting